March 08, 2021
By Victoria Johnson
Ishu Arpan, PhD, senior research associate at Oregon Health & Science University, discussed her team’s investigations into identifying patients with MS at risk of falling.
March 08, 2021
By Marco Meglio
Increases in reperfusion treatment were the largest in lowest-volume hospitals, among rural residents, and among patients aged 85 years and older.
March 08, 2021
By NeurologyLive Staff
Here's what is coming soon to NeurologyLive.
March 07, 2021
By Matt Hoffman
The 2-stage study is an open-label, 2-stage clinical trial designed to evaluate safety and dose-escalation (stage 1) and safety and efficacy (stage 2) of surgically delivered AXO-AAV-GM2.
March 07, 2021
By Marco Meglio
Patients having a relapse, confirmed disability accumulation, or worsening in fatigue had significant negative impact on each of the work productivity and activity impairment measures.